ClinicalTrials.gg
CompletedNCT07872410Updated Oct 13, 2026

Laparoscopic Extended View Totally Extra Peritoneal (e.TEP) in Comparison to Traditional TEP Technique for Inguinal Hernia Repair

An interventional study of Totally extra peritoneal and Extended view totally extra peritoneal in Laparoscopic, Extended View and Totally Extra Peritoneal, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Nov 2024, registered Oct 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this prospective randomized clinical study is to compare effectiveness, feasibility and outcome between total extra peritoneal (TEP) and extended TEP (E-TEP) techniques in repair of inguinal hernia.

Read the detailed description

Groin hernias are the most common conditions referred to surgeons all over the world .The lifetime risk for men is 27.0% and for women is 3.0%. Approximately 75.0% of all abdominal wall hernias occur in the groin.

The techniques which are practiced now for hernia repair are mainly : Transabdominal pre-peritoneal (TAPP) ,Total extra peritoneal (TEP) ,Intraperitoneal only meshplasty(IPOM). Each technique has its own applications and pitfalls and has a very gradual learning curve; hence, they have remained confined to the expert hands only.

02

Conditions studied

  • Laparoscopic
  • Extended View
  • Totally Extra Peritoneal
  • Inguinal Hernia Repair
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,115 studies on the registry; 184 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with inguinal hernias.
  • Patients above 18 years old
  • Fit for general anesthesia.
  • Agree to participate in the study.
  • male gender only will be included.

Exclusion criteria

Exclusion Criteria:

  • Unfitness for general anesthesia and operation.
  • Complicated hernias (acute irreducible, obstruction or strangulation).
  • The presence of mental or psychological disorders.
  • Refusal to participate in the study.
  • Patients with recurrence after laparoscopic repair.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Active comparator
    TEP group

    Patients underwent the totally extra peritoneal (TEP) approach

    Procedure: Totally extra peritoneal

  • Experimental
    eTEP group

    Patients underwent the extended view totally extra peritoneal (eTEP) approach

    Procedure: Extended view totally extra peritoneal

Interventions

  • ProcedureTotally extra peritoneal

    Patients underwent the totally extra peritoneal (TEP) approach

  • ProcedureExtended view totally extra peritoneal

    Patients underwent the extended view totally extra peritoneal (eTEP) approach

06

What researchers measure

Primary outcomes

  1. Degree of pain

    Each patient will be instructed about postoperative pain assessment with the visual analog scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable").

    Time frame: 24 hours postoperatively

07

Study locations

1 site
  • Mansoura University
    Al Mansurah, Dakahlia Governorate 35516, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872410
Responsible party
Salma Samra (Resident of General Surgery, Mansoura University, Mansoura, Egypt., Mansoura University) — Principal investigator
First posted
Oct 13, 2026
Start date
Nov 1, 2024
Primary completion
Nov 1, 2025
Completion
Nov 1, 2025
Last update
Oct 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion